Nadia Blanchet, MD
Plastic and Reconstructive Surgery · Richmond, VANPI 1851402515
Payments from drug & device makers
What this record shows
The money is spread across several categories — gifts (50.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by AbbVie at 53.9% of the total. Reporting peaked in 2019 at $2,421 and has fallen 97.5% since, to $62 in 2025.
Across 49 payments — averaging $77.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Musculoskeletal Transplant Foundation Inc.$1K
- Mentor Worldwide LLC$257
- Galderma Laboratories, L.p.$132
- Revance Therapeutics, Inc.$62
- TELA Bio, Inc.$38
- plus $125 from 5 others
What the payments were for
- Food & beverage$1,87149%
- Education$281%
- Gifts$1,91150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 9 | $2,052 |
| Musculoskeletal Transplant Foundation Inc. | 18 | $1,143 |
| Mentor Worldwide LLC | 5 | $257 |
| Galderma Laboratories, L.p. | 7 | $132 |
| Revance Therapeutics, Inc. | 2 | $62 |
| TELA Bio, Inc. | 1 | $38 |
| Pacira Pharmaceuticals Incorporated | 2 | $31 |
| BD | 1 | $28 |
| Sientra, Inc. | 2 | $25 |
| Acell, Inc. | 1 | $22 |
| KCI USA, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE$1,911
- MemoryGel Breast Implants$125
How this compares
$3,810 in reported general payments places this provider in the 55th percentile of 77 plastic and reconstructive surgery providers in Virginia.
See all plastic and reconstructive surgery providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 29 | $520 |
| Montelukast Sodium | 40 | $169 |
| Cefadroxil | 44 | $147 |
| Tranexamic Acid | 28 | $131 |
| Ondansetron OdtOndansetron | 22 | $127 |
| Acyclovir | 17 | $38 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 23 | $31 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Richmond
- Neil ZemmelRichmond$38K
- Lauren NigroRichmond$28K
- Burton SundinRichmond$23K
- Karishma ReddyRichmond$7K
- Robert DecontiRichmond$5K
- Lewis LadocsiRichmond$5K
- Isaac WornomRichmond$4K
- Annabel BaekRichmond$4K
- Leslie CohenRichmond$3K
- Santosh KaleRichmond$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.